- Home
- VRDN vs BY Comparison
VRDN vs BY Comparison
Compare VRDN & BY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- BY
- Stock Information
- Founded
- VRDN 2006
- BY 1914
- Country
- VRDN United States
- BY United States
- Employees
- VRDN N/A
- BY N/A
- Industry
- VRDN Medical Specialities
- BY Major Banks
- Sector
- VRDN Health Care
- BY Finance
- Exchange
- VRDN Nasdaq
- BY Nasdaq
- Market Cap
- VRDN 1.0B
- BY 1.1B
- IPO Year
- VRDN N/A
- BY 2017
- Fundamental
- Price
- VRDN $14.16
- BY $25.82
- Analyst Decision
- VRDN Strong Buy
- BY Hold
- Analyst Count
- VRDN 12
- BY 3
- Target Price
- VRDN $38.50
- BY $33.67
- AVG Volume (30 Days)
- VRDN 838.2K
- BY 133.8K
- Earning Date
- VRDN 05-06-2025
- BY 07-24-2025
- Dividend Yield
- VRDN N/A
- BY 1.55%
- EPS Growth
- VRDN N/A
- BY N/A
- EPS
- VRDN N/A
- BY 2.69
- Revenue
- VRDN $302,000.00
- BY $379,386,000.00
- Revenue This Year
- VRDN N/A
- BY $16.23
- Revenue Next Year
- VRDN $21,976.14
- BY $3.79
- P/E Ratio
- VRDN N/A
- BY $9.62
- Revenue Growth
- VRDN 4.86
- BY 3.48
- 52 Week Low
- VRDN $9.90
- BY $21.96
- 52 Week High
- VRDN $27.20
- BY $32.89
- Technical
- Relative Strength Index (RSI)
- VRDN 55.33
- BY 43.73
- Support Level
- VRDN $13.37
- BY $25.57
- Resistance Level
- VRDN $14.18
- BY $27.30
- Average True Range (ATR)
- VRDN 0.67
- BY 0.35
- MACD
- VRDN 0.12
- BY -0.15
- Stochastic Oscillator
- VRDN 71.43
- BY 7.51
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About BY Byline Bancorp Inc.
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.